Systematic Computational Optimization and Population Shift Analysis of 8-Substituted Adenosine Analogs: A Multi-Parameter Framework for Navigating the KRAS G12D Switch II Pocket
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
The therapeutic inhibition of the KRAS G12D mutation remains a paramount challenge in precision oncology, as the chemically inert and negatively charged aspartate residue at position 12 necessitates high-fidelity non-covalent intervention. In this study, we propose a rational design strategy based on an 8-aryl-adenosine scaffold, utilizing strategic C8-functionalization as a stereoelectronic “conformational lock.” By inducing a stable syn -conformation of the glycosidic bond, we effectively vectorize functional groups toward the Switch II cryptic pocket (SII-P), enabling critical molecular recognition patterns—specifically a bifurcated hydrogen-bonding network with the mutant Asp12—that are spatially inaccessible to natural adenosine. To navigate the chemical space of 100 rationally designed analogs, we implemented a multi-parameter computational framework integrating CNN-driven molecular docking via the GNINA engine with a novel Population Shift Analysis (PSA). Our results demonstrate a definitive library-wide thermodynamic migration toward superior binding affinities, with optimized candidates breaching the -5.0 kcal/mol threshold (reaching a minimum of -5.22 kcal/mol ). Statistical determinants reveal that this potency gain is orthogonal to molecular mass accumulation ( r = 0.24 ) and is instead driven by exceptional Lipophilic Ligand Efficiency ( LLE , r = -0.95 ), proving that binding efficacy is a direct consequence of precise structural vectorization. Among the evaluated ensemble, Acetamide and Mixed-Halogen derivatives are nominated as high-priority leads for experimental validation, exhibiting optimal electrostatic complementarity and sub-cavity occupancy. This study provides a robust, scalable blueprint for the transformation of simple nucleoside fragments into high-efficiency, site-directed leads targeting one of oncology’s most elusive and lethal targets.